SSI Investment Management’s AbbVie ABBV Stock Holding History

SSI Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$290K	Hold	1,334	–	–	0.02%	213
2025 Q4	$305K	Hold	1,334	–	–	0.02%	223
2025 Q3	$309K	Hold	1,334	–	–	0.02%	225
2025 Q2	$248K	Sell	1,334 -1,008	-43%	-$187K	0.02%	238
2025 Q1	$491K	Sell	2,342 -1	-0%	-$194	0.04%	201
2024 Q4	$416K	Sell	2,343 -2	-0.1%	-$368	0.03%	220
2024 Q3	$463K	Sell	2,345 -1	-0%	-$187	0.03%	212
2024 Q2	$402K	Sell	2,346 -2	-0.1%	-$331	0.03%	206
2024 Q1	$428K	Sell	2,348 -32	-1%	-$5.51K	0.03%	205
2023 Q4	$369K	Sell	2,380 -10	-0.4%	-$1.46K	0.03%	220
2023 Q3	$356K	Sell	2,390 -30	-1%	-$4.4K	0.03%	203
2023 Q2	$326K	Sell	2,420 -420	-15%	-$61.6K	0.02%	219
2023 Q1	$453K	Sell	2,840 -667	-19%	-$102K	0.03%	203
2022 Q4	$567K	Hold	3,507	–	–	0.04%	219
2022 Q3	$473K	Hold	3,507	–	–	0.03%	219
2022 Q2	$536K	Hold	3,507	–	–	0.03%	220
2022 Q1	$570K	Sell	3,507 -43	-1%	-$6.25K	0.03%	218
2021 Q4	$482K	Sell	3,550 -10	-0.3%	-$1.18K	0.03%	230
2021 Q3	$386K	Buy	3,560 +23	+0.7%	+$2.63K	0.02%	245
2021 Q2	$400K	Sell	3,537 -16	-0.5%	-$1.8K	0.03%	248
2021 Q1	$385K	Sell	3,553 -2	-0.1%	-$214	0.03%	241
2020 Q4	$381K	Sell	3,555 -4	-0.1%	-$384	0.03%	220
2020 Q3	$313K	Sell	3,559 -100	-3%	-$9.41K	0.03%	224
2020 Q2	$360K	Buy	3,659 +318	+10%	+$28K	0.03%	210
2020 Q1	$256K	Sell	3,341 -39	-1%	-$3.32K	0.02%	221
2019 Q4	$300K	Sell	3,380 -10	-0.3%	-$830	0.02%	248
2019 Q3	$257K	Sell	3,390 -3	-0.1%	-$206	0.02%	256
2019 Q2	$245K	Sell	3,393 -14	-0.4%	-$1.1K	0.02%	259
2019 Q1	$272K	Sell	3,407 -10	-0.3%	-$818	0.02%	250
2018 Q4	$315K	Sell	3,417 -13	-0.4%	-$1.14K	0.03%	225
2018 Q3	$325K	Sell	3,430 -16	-0.5%	-$1.52K	0.03%	254
2018 Q2	$320K	Sell	3,446 -434	-11%	-$42.4K	0.03%	242
2018 Q1	$367K	Sell	3,880 -59	-1%	-$6.48K	0.03%	248
2017 Q4	$380K	Sell	3,939 -5	-0.1%	-$471	0.03%	247
2017 Q3	$351K	Sell	3,944 -24	-0.6%	-$1.83K	0.03%	256
2017 Q2	$286K	Sell	3,968 -46	-1%	-$3.09K	0.03%	270
2017 Q1	$261K	Sell	4,014 -5	-0.1%	-$314	0.02%	270
2016 Q4	$252K	Sell	4,019 -82	-2%	-$5K	0.02%	266
2016 Q3	$258K	Sell	4,101 -53	-1%	-$3.43K	0.02%	259
2016 Q2	$256K	Buy	4,154 +69	+2%	+$4.2K	0.02%	246
2016 Q1	$233K	Buy	4,085 +1	+0%	+$56	0.02%	245
2015 Q4	$242K	Hold	4,084	–	–	0.02%	250
2015 Q3	$222K	Hold	4,084	–	–	0.02%	257
2015 Q2	$274K	Sell	4,084 -4,548	-53%	-$297K	0.03%	251
2015 Q1	$504K	Sell	8,632 -5,043	-37%	-$305K	0.05%	200
2014 Q4	$896K	Buy	13,675 +1,521	+13%	+$95.9K	0.09%	173
2014 Q3	$700K	Buy	12,154 +250	+2%	+$13.9K	0.07%	186
2014 Q2	$671K	Sell	11,904 -210	-2%	-$11K	0.07%	186
2014 Q1	$625K	Sell	12,114 -6,948	-36%	-$351K	0.06%	196
2013 Q4	$1.01M	Sell	19,062 -14,196	-43%	-$698K	0.09%	222
2013 Q3	$1.49M	Buy	33,258 +14,928	+81%	+$662K	0.13%	159
2013 Q2	$756K	Buy	+18,330	New	+$802K	0.07%	248

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SSI Investment Management's ABBV Position: Q1 2026 in Review

SSI Investment Management held its AbbVie (ABBV) position steady in Q1 2026 at 1,334 shares worth $290K. The position accounts for 0.02% of the portfolio, ranked #213.

SSI Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.49M in Q3 2013. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

SSI Investment Management held 1,334 shares of AbbVie worth $290K as of Q1 2026.
SSI Investment Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.02% of SSI Investment Management's portfolio in Q1 2026, its #213 holding.
SSI Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
SSI Investment Management's AbbVie position peaked at $1.49M in Q3 2013.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on SSI Investment Management's 13F filing for Q1 2026, filed 14 May 2026.